Can-Fite BioPharma Ltd.

CANF · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,825$4,278$2,978$4,390
Short-Term Investments$3,062$4,644$5,001$14,749
Receivables$77$78$47$48
Inventory$0$0-$39-$48
Other Curr. Assets$1,018$908$1,170$929
Total Curr. Assets$8,982$9,908$9,157$20,068
Property Plant & Equip (Net)$138$81$126$185
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$8$0
Tax Assets$0$0$0$0
Other NC Assets$0$0-$8$0
Total NC Assets$138$81$126$185
Other Assets$0$0$0$0
Total Assets$9,120$9,989$9,283$20,253
Liabilities
Payables$618$427$896$954
Short-Term Debt$106$54$96$106
Tax Payable$0$0$0$0
Deferred Revenue$405$622$783$818
Other Curr. Liab.$923$917$727$852
Total Curr. Liab.$2,052$2,020$2,502$2,730
LT Debt$51$13$14$71
Deferred Rev, NC$1,581$1,713$2,295$3,070
Deferred Tax Liab, NC$0$0-$2,295-$3,070
Other NC Liab.$0$0$2,295$3,070
Total NC Liab.$1,632$1,726$2,309$3,141
Other Liabilities$0$0$0$0
Cap. Leases$104$40$62$124
Total Liabilities$3,684$3,746$4,811$5,871
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$60,654
Retained Earnings-$166,361-$158,481-$150,847-$140,674
AOCI$1,127$1,127$1,127$1,127
Other Equity$170,670$163,597$154,192$153,929
Total Equity$5,436$6,243$4,472$14,382
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$9,120$9,989$9,283$20,253
Net Debt-$4,668-$4,211-$2,868-$4,213
Can-Fite BioPharma Ltd. (CANF) Financial Statements & Key Stats | AlphaPilot